Xenon Pharmaceuticals (XENE) Stock Price, Quote, News & History

Comments

Xenon Pharmaceuticals Inc (XENE) Stock Price, Quote, News & History

XENENASDAQ

Trade with Public

$56.85

0.160.28%

At close: Apr 2, 5:00 PM EST

$56.85

N/A

After Hours: Apr 2, 4:28 PM EST

OverviewNews Earnings Options Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$56.00

Close

$56.85

Volume / Avg.

897.52K / 1.42M

Day Range

$55.86 - $57.44

52 Wk Range

26.74 - 63.95

Market Cap

$5.43B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

62

Short Interest

6.23%

Days to Cover

1.7

Recent Xenon Pharmaceuticals Inc News

What's Going On With Biohaven Stock On Monday?

Biohaven shares rose in premarket trading after Xenon's Phase 3 epilepsy study showed strong seizure reduction results.

Vandana Singh

Xenon Pharmaceuticals Rallies After Pivotal Data Shows Major Drop In Monthly Seizures

Xenon Pharmaceuticals shares surge after Phase 3 data show strong seizure reduction for azetukalner, with FDA filing planned for 2026.

Vandana Singh

Biohaven Misses The Mark In Depression Trial, Stock Falls

Biohaven's Phase 2 study with BHV-7000 in MDD did not meet its primary endpoint of reducing depressive symptoms in comparison to placebo.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-279.12M

Investing Cash Flow (TTM)

218.00M

Financing Cash Flow (TTM)

117.11M

Free Cash Flow (TTM)

-279.92M

Capital Expenditure (TTM)

-799.00K

Net Change in Cash (TTM)

55.99M

Analyst Trends and Forecast

1

Dec 25

1

Jan

3

Feb

7

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$4.88B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

598.74

PB Ratio (TTM)

9.29

Earnings Yield % (TTM)

-7.70%

Earnings Yield % (FWD)

-8.58%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$6.10

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$199.16M

Debt to Equity

0.01

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$56.00

Close

$56.85

Volume / Avg.

897.52K / 1.42M

Day Range

$55.86 - $57.44

52 Wk Range

26.74 - 63.95

Market Cap

$5.43B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

62

Short Interest

6.23%

Days to Cover

1.7

About

Sector

Health Care

Industry

Biotechnology

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medic...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Xenon Pharmaceuticals (XENE) stock?

A

You can purchase shares of Xenon Pharmaceuticals (NASDAQ:XENE) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Xenon Pharmaceuticals (XENE) competitors?

A

Other companies in Xenon Pharmaceuticals’s space includes: Immunovant Inc (NASDAQ:IMVT), Cogent Biosciences Inc (NASDAQ:COGT), Celcuity Inc (NASDAQ:CELC), Centessa Pharmaceuticals PLC (NASDAQ:CNTA) and Alkermes PLC (NASDAQ:ALKS).

Q

What is the forecast, or price target, for Xenon Pharmaceuticals (XENE) stock?

A

Xenon Pharmaceuticals has a consensus price target of $63.05.

Q

What is the current price for Xenon Pharmaceuticals (XENE)?

A

The stock price for Xenon Pharmaceuticals (NASDAQ: XENE) is $56.85 last updated April 2, 2026 at 4:28 PM EDT.

Q

Does Xenon Pharmaceuticals (XENE) pay a dividend?

A

There are no upcoming dividends for Xenon Pharmaceuticals.

Q

When is Xenon Pharmaceuticals (NASDAQ:XENE) reporting earnings?

A

Xenon Pharmaceuticals does not have any upcoming earnings scheduled.

Q

Is Xenon Pharmaceuticals (XENE) going to split?

A

There is no upcoming split for Xenon Pharmaceuticals.

Q

What sector and industry does Xenon Pharmaceuticals (XENE) operate in?

A

Xenon Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

Cogent Biosciences Inc

Centessa Pharmaceuticals PLC

Protagonist Therapeutics Inc

Key Statistics

Open

$56.00

Close

$56.85

Volume / Avg.

897.52K / 1.42M

Day Range

$55.86 - $57.44

52 Wk Range

26.74 - 63.95

Market Cap

$5.43B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

62

Short Interest

6.23%

Days to Cover

1.7

Recent Xenon Pharmaceuticals Inc News

What's Going On With Biohaven Stock On Monday?

Biohaven shares rose in premarket trading after Xenon's Phase 3 epilepsy study showed strong seizure reduction results.

Vandana Singh

Xenon Pharmaceuticals Rallies After Pivotal Data Shows Major Drop In Monthly Seizures

Xenon Pharmaceuticals shares surge after Phase 3 data show strong seizure reduction for azetukalner, with FDA filing planned for 2026.

Vandana Singh

Biohaven Misses The Mark In Depression Trial, Stock Falls

Biohaven's Phase 2 study with BHV-7000 in MDD did not meet its primary endpoint of reducing depressive symptoms in comparison to placebo.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-279.12M

Investing Cash Flow (TTM)

218.00M

Financing Cash Flow (TTM)

117.11M

Free Cash Flow (TTM)

-279.92M

Capital Expenditure (TTM)

-799.00K

Net Change in Cash (TTM)

55.99M

Analyst Trends and Forecast

1

Dec 25

1

Jan

3

Feb

7

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$4.88B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

598.74

PB Ratio (TTM)

9.29

Earnings Yield % (TTM)

-7.70%

Earnings Yield % (FWD)

-8.58%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$6.10

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$199.16M

Debt to Equity

0.01

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$56.00

Close

$56.85

Volume / Avg.

897.52K / 1.42M

Day Range

$55.86 - $57.44

52 Wk Range

26.74 - 63.95

Market Cap

$5.43B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

62

Short Interest

6.23%

Days to Cover

1.7

About

Sector

Health Care

Industry

Biotechnology

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medic...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry